Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School
Federal Trade Commission

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089894

« Back to Dashboard

NDA 089894 describes QUINIDINE GLUCONATE, which is a drug marketed by Lilly, Ascot, Aurolife Pharma Llc, Cycle Pharms Ltd, Halsey, Sun Pharm Industries, Superpharm, and Watson Labs, and is included in nine NDAs. It is available from four suppliers. Additional details are available on the QUINIDINE GLUCONATE profile page.

The generic ingredient in QUINIDINE GLUCONATE is quinidine gluconate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the quinidine gluconate profile page.
Summary for 089894
Applicant:Aurolife Pharma Llc
Ingredient:quinidine gluconate
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength324MG
Approval Date:Dec 15, 1988TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.